Analyst
Individual Investor
Equibles does not estimate personal net worth.
Shikhar Jain is recorded as Analyst at Individual Investor. Shikhar Jain has spoken on 1 earnings call across 1 company, most recently for Natco Pharma Limited on November 13, 2026. The companies whose calls Shikhar Jain spoke on are classified in the Healthcare sector.
“In March, when we announced that we have first to file status for pomalidomide, I was hoping for a bit of a bump. So, what happened with the pomalidomide first to file status?”
Individual Investor
Analyst
Transcript header (unverified)
Natco Pharma Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call for the Quarter Ended September 30, 2026
Natco Pharma Limited
